Pricing Log in Create free account

Cellectis S.A. (CLLS) vs Nutriband Inc. (NTRB)

Cellectis S.A. and Nutriband Inc. are both Biotechnology companies. Cellectis S.A. and Nutriband Inc. are of similar size ($79.9M and $76.2M). Cellectis S.A. grew revenue faster over the last twelve months: 0.61% against −37.3%. Cellectis S.A. has the higher net margin (−102.3% vs −430.4%) and the higher return on invested capital (0.00% vs −227.9%). Across the 18 metrics below, Cellectis S.A. leads on 12 and Nutriband Inc. on 6.

Valuation

Metric CLLS NTRB Biotechnology median
P/E n/m n/m 8.50
P/S 1.64 46.74 9.71
P/B 2.55 14.20 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.18 44.68 9.21
Earnings yield (62.89%) (9.21%) (33.15%)
Free cash flow yield (44.14%) (4.81%) (25.50%)

Profitability

Metric CLLS NTRB Biotechnology median
Gross margin 100.00% 33.14% 65.16%
Operating margin (90.88%) (435.57%) 0.00%
Net margin (102.34%) (430.43%) 0.00%
Free cash flow margin (68.63%) (224.54%) 0.00%
Return on equity (94.54%) (100.79%) (56.36%)
Return on assets (21.02%) (84.56%) (48.04%)
Return on invested capital 0.00% (227.92%) 0.00%

Growth

Metric CLLS NTRB Biotechnology median
Revenue growth (TTM) 0.61% (37.25%) 6.02%
EPS growth (last fiscal year) (63.41%) (160.61%) 30.26%
Revenue growth, 5-year CAGR (0.70%) 16.63% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLLS NTRB Biotechnology median
Debt to equity 1.79 0.00 0.00
Current ratio 1.37 4.21 4.72
Net debt to EBITDA 9.54 0.56 0.96

Dividend

Metric CLLS NTRB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLLS NTRB Biotechnology median
Market cap 79.92m 76.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack